跳至主要内容
临床试验/EUCTR2010-018767-42-IT
EUCTR2010-018767-42-IT进行中(未招募)不适用

The use of Contrast Enhanced Transesophageal Echocardiography in thoracic endovascular aortic repair (TEVAR). Feasibility and safety of a new tool for intraoperative monitoring and follow up. - ND

FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR0 个研究点开始时间: 2010年3月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • patients elegible for endovascular treatment of descending thoracic aorta diseases. Patient will be already known for type 2 aortic dissection (n=x), for aortic penetrating ulcer, for anurysms of descending thoracic aorta (n=y). The indication for TEVAR, as for open surgery, is generally accepted for aneurysm of the descending thoracic aorta greater than 5.5 cm. Another indication is type B aortic dissection with aneurismal evolution that reach the 5.5 cm criteria.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • patients aged below 18 years old; contraindication to M.D.C. use

研究者

发起方
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR

相似试验